PharmStockPharmacy Stock

Dapsone
Dapsone

0.06
For patients managing skin conditions, this generic medicine inhibits bacterial nucleic acid synthesis. Reduces inflammation and blocks the growth of bacteria within the skin.
Ingredient
Dapsone
Category
Skin Care
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Dapsone
Reference Brand
Aczone
Product Origin
Generic Product
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Skin Care
Product Category
Sulfone Antibiotic
Pharmacological Class
Topical Acne Agent
Manufacturer Description
Developed to mitigate bacterial and inflammatory skin lesions to support healthy dermal integrity and alleviate chronic itching.
Mechanism of Action
Inhibits synthesis of dihydrofolic acid inside target microbes and reduces inflammatory myeloperoxidase activity.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
12–24 hours
Contraindications
Severe hypersensitivity to dapsone
Severe Adverse Events
Agranulocytosis — requires immediate medical attention, Severe peripheral neuropathy — requires immediate medical attention
Common Side Effects
Headache, Nausea, Vomiting
Uncommon Side Effects
Methemoglobinemia, Hemolytic anemia, Local skin irritation
Drug Interactions
Rifampin, Trimethoprim, Probenecid
Pregnancy Safety Warnings
TGA Category C: Use if potential benefits outweigh risks. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for adults and children over twelve years.
Storage Guidelines
Store below 25°C.
Related Products
Cleocin-gel, Differin
Information related to Dapsone is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to order Thyroid Medication Australia - Levothyroxine Hypothyroid T4 Tablet